Metabolic Profiles of Whole Serum and Serum-Derived Exosomes Are Different in Head and Neck Cancer Patients Treated by Radiotherapy

Anna Wojakowska, Aneta Zebrowska, Agata Skowronek, Tomasz Rutkowski, Krzysztof Polański, Piotr Wiland, Łukasz Marczak, Monika PietrowskaJournal of Personalized Medicine 2020 · DOI

TL;DR

This study investigated the metabolic profiles of both whole serum and serum-derived exosomes in head and neck cancer (HNC) patients undergoing radiotherapy (RT). They found that while cancer-related metabolic changes, particularly in energy metabolism, are detectable in both serum and exosomes, radiotherapy significantly alters serum metabolites but not exosome metabolites, suggesting exosomes might offer a more stable snapshot of the cancer state.

What Problem Does This Paper Address?

Head and neck cancer (HNC) is a significant global health challenge. While treatments like radiotherapy (RT) have improved, there's a continuous need for better diagnostic and prognostic biomarkers. Liquid biopsies, particularly those derived from exosomes, are gaining traction as they offer a less invasive way to access biological information. However, the metabolic content of these exosomes, especially in the context of cancer treatment like RT, remains underexplored. This paper aims to bridge this gap by comparing the metabolic profiles of whole serum and serum-derived exosomes in HNC patients before and after RT, and against healthy controls, to understand how cancer and its treatment manifest in these two distinct biological compartments.

Methods

The researchers employed a gas chromatography-mass spectrometry (GC-MS) based untargeted metabolomics approach.

  • Sample Collection: Blood samples were collected from HNC patients before and after RT, as well as from healthy controls.
  • Exosome Isolation: Serum-derived exosomes were isolated using a combination of differential centrifugation and size exclusion chromatography (SEC). Exosome characterization was performed using dynamic light scattering (DLS), transmission electron microscopy (TEM), and Western blotting for exosome markers (CD63, CD81).
  • Metabolite Extraction: Metabolites were extracted from both serum and isolated exosomes using methanol.
  • GC-MS Analysis: The extracted metabolites were derivatized and analyzed using GC-MS.
  • Data Analysis: Statistical analysis included t-tests, Welch tests, and Mann-Whitney U tests to identify differences between groups. Effect sizes (RBCC for independent samples, Cohen's d for paired samples) were used to quantify the magnitude of these differences, especially given the small sample size. Principal component analysis (PCA) and hierarchical cluster analysis (HCA) were used for sample clustering. Metabolic pathway enrichment analysis was performed using MetaboAnalyst.

Datasets

The study utilized serum and serum-derived exosome samples from:

  • 10 HNC patients (collected before and after radiotherapy).
  • 10 age- and sex-matched healthy volunteers.

No new public datasets were introduced or used for benchmarking.

Key Insights and Ideas

  • Exosomes are metabolically less complex than serum: The untargeted GC-MS approach identified significantly fewer metabolites in exosomes (46) compared to whole serum (182), suggesting a more curated cargo or lower overall concentration within exosomes.
  • Cancer's metabolic signature is present in both: Key metabolic alterations associated with cancer, particularly those related to energy metabolism (e.g., Warburg effect, glycolysis, TCA cycle), were detectable in both whole serum and serum-derived exosomes. This highlights the potential of exosomes as a source for cancer biomarkers.
  • Radiotherapy's impact is differential: While RT induced significant changes in the serum metabolome, affecting pathways related to amino acids, sugars, lipids, and nucleotides, it did not appear to cause a distinct, detectable pattern of change in the exosome metabolome in this pilot study. This suggests that exosomes might reflect a more stable, cancer-specific metabolic state, less perturbed by acute treatment effects compared to the broader systemic changes seen in serum.
  • Lipid metabolism in exosomes: Interestingly, pathways related to fatty acid oxidation and ketone body metabolism were specifically highlighted for serum-derived exosomes in cancer patients, potentially indicating a role for exosomes in mediating lipid metabolism changes related to cancer.

Key Results

  • Metabolite Identification: 182 metabolites were identified in serum samples and 46 in exosome samples. 33 metabolites were common to both.
  • Cancer vs. Control (Serum): 27 serum metabolites showed a large effect size difference between cancer patients and controls, primarily related to energy metabolism.
  • Cancer vs. Control (Exosomes): Only a few exosome metabolites showed significant differences, with 1-hexadecanol upregulated and citric acid, 4-hydroxybenzoic acid, and propylene glycol downregulated in cancer patients.
  • Radiotherapy Effects (Serum): 12 serum metabolites showed large effect size differences between pre-RT and post-RT samples, indicating broad metabolic shifts due to radiation.
  • Radiotherapy Effects (Exosomes): Only two exosome metabolites (glycerol and cholesterol) showed reduced levels post-RT with a medium effect size, suggesting a lack of significant RT-induced changes in exosome metabolites.

Limitations and Future Work

  • Small Sample Size: The authors acknowledge that the small sample size limits the statistical power and the ability to achieve significant results after FDR correction, necessitating the use of effect sizes. This is a critical limitation for drawing definitive conclusions.
  • Exosome Heterogeneity: The study acknowledges that the isolated fraction might contain other subpopulations of small extracellular vesicles besides exosomes.
  • Limited RT Impact on Exosomes: The lack of a clear radiation-related pattern in exosome metabolites is a key finding but also a limitation in identifying RT-specific exosomal biomarkers.
  • Future Work: The authors emphasize the need for larger cohort studies to validate these findings and to further investigate the role of serum EVs in mediating cancer-related lipid metabolism. They also suggest that future research should address the potential role of metabolites in exosomes in radiation-related cell-to-cell signaling.

Summary updated

Abstract

cancer-related features of energy metabolism could be detected in both types of specimens. On the other hand, in contrast to RT-induced changes observed in serum metabolome, this pilot study did not reveal a specific radiation-related pattern of exosome metabolites.
BibTeX
@article{wojakowska2020metabolic,
  author = {Anna Wojakowska and Aneta Zebrowska and Agata Skowronek and Tomasz Rutkowski and Krzysztof Polański and Piotr Wiland and Łukasz Marczak and Monika Pietrowska},
  title = {{Metabolic Profiles of Whole Serum and Serum-Derived Exosomes Are Different in Head and Neck Cancer Patients Treated by Radiotherapy}},
  journal = {Journal of Personalized Medicine},
  year = {2020},
  doi = {10.3390/jpm10040229},
}
Figure